Trophos Raises Series C

Trophos SA, a Marseille, France-based drug company focused on neurological disorders, has raised EUR 8.5 million ($11.6m) in Series C funding. OTC Asset Management led the round, and was joined by CM-CIC Capital Prive and return backers SGAM, Viveris Management, Turenne Capital Partners, Blue Medical and the Association Fran